Patents by Inventor Moon-Jae Cho

Moon-Jae Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION USING 4',6,7-TRIMETHOXYISOFLAVONE AND CATECHOL FOR MANAGING PULMONARY FIBROSIS
    Publication number: 20220218655
    Abstract: Proposed is a composition for managing pulmonary fibrosis. The composition uses 4?,6,7-trimethoxyisoflavone and catechol that does not cytotoxicity and inhibits a TGF-?1 signal transfer pathway, thereby exhibiting EMT inhibitory activity.
    Type: Application
    Filed: July 6, 2021
    Publication date: July 14, 2022
    Inventors: Moon Jae CHO, Young Mee KIM, Bong Jo SON
  • Methods of screening for compounds which mimic galectin-1
    Patent number: 6225071
    Abstract: Methods for treating and modulating an inflammatory response using compositions containing a primarily monomeric or primarily dimeric form of galectin-1. The dimeric form stimulates apoptosis of activated neutrophils while the monomeric form inhibits apoptosis of activated neutrophils. Methods of screening for compounds which have galectin-1-like functions are also identified.
    Type: Grant
    Filed: July 1, 1999
    Date of Patent: May 1, 2001
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Richard D. Cummings, Moon-Jae Cho
  • Method for making activated neutrophils recognizable to macrophages
    Patent number: 6054315
    Abstract: Methods for treating and modulating an inflammatory response using compositions containing a primarily monomeric or primarily dimeric form of galectin-1. The dimeric form stimulates apoptosis of activated neutrophils while the monomeric form inhibits apoptosis of activated neutrophils. Methods of screening for compounds which have galectin-1-like functions are also identified.
    Type: Grant
    Filed: September 5, 1997
    Date of Patent: April 25, 2000
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Richard D. Cummings, Moon-Jae Cho
  • Methods of screening for compounds which mimic galectin-1
    Patent number: 5948628
    Abstract: Methods for treating and modulating an inflammatory response using compositions containing a primarily monomeric or primarily dimeric form of galectin-1. The dimeric form stimulates apoptosis of activated neutrophils while the monomeric form inhibits apoptosis of activated neutrophils. Methods of screening for compounds which have galectin-1-like functions are also identified.
    Type: Grant
    Filed: September 5, 1997
    Date of Patent: September 7, 1999
    Assignee: The Board of Regents of The University of Oklahoma
    Inventors: Richard D. Cummings, Moon-Jae Cho